Oncorus, Inc. (ONCR) stock is getting down to 7.38% – What’re the reasons?
Oncorus, Inc. (ONCR) experiences a decline of 7.38% in the aftermarket. However, the last trading session closed at $5.83 with a decrease of 1.19%. Phase 1 Clinical Study of ONCR-177 On 12th November 2021, the company announced that ONCR-177 is now being studied in a Phase 1 open-label, multi-center, dosage progression, and expansion clinical study. […]
Oncorus, Inc. (ONCR) stock is getting down to 7.38% – What’re the reasons? Read More »